Skip to main content
SpringerLink
Log in

Triple H Therapy

  • Chapter
  • First Online:
Neuroimaging Pharmacopoeia

  • 301 Accesses

Abstract

The combination of induced hypertension, hypervolemia, and hemodilution constitutes triple H therapy is an option for preventing and treating cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Although strong clinical evidence is lacking, this therapy may be appropriate for selected cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14(1):R23.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jang HW, Lee HJ. Posterior reversible leukoencephalopathy due to “triple H” therapy. J Clin Neurosci. 2010;17(8):1059–61.

    Article  PubMed  Google Scholar 

  • Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care. 2006;4(1):68–76.

    Article  PubMed  Google Scholar 

  • Meyer R, Deem S, Yanez ND, Souter M, Lam A, Treggiari MM. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage. Neurocrit Care. 2011;14(1):24–36.

    Article  PubMed  Google Scholar 

  • Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2003;2(10):614–21.

    Article  PubMed  Google Scholar 

  • Wartenberg KE, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging. 2006;16(2):170–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University of Chicago, Chicago, IL, USA

    Daniel Thomas Ginat

Authors
  1. Daniel Thomas Ginat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Thomas Ginat .

Editor information

Editors and Affiliations

  1. Department of Radiology, University of Chicago, Chicago, IL, USA

    Daniel Thomas Ginat

  2. Diagnostic Radiology, Lahey Hospital and Medical Center, Burlington, MA, USA

    Juan E. Small

  3. Department of Neuroradiology, Massachusetts General Hospital, Boston, MA, USA

    Pamela Whitney Schaefer

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ginat, D.T. (2022). Triple H Therapy. In: Ginat, D.T., Small, J.E., Schaefer, P.W. (eds) Neuroimaging Pharmacopoeia. Springer, Cham. https://doi.org/10.1007/978-3-031-08774-5_51

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-08774-5_51

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-08773-8

  • Online ISBN: 978-3-031-08774-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation